Chase Knickerbocker analyst CRAIG HALLUM

Currently out of the existing stock ratings of Chase Knickerbocker, 92 are a BUY (97.87%), 2 are a HOLD (2.13%).

Chase Knickerbocker

Work Performance Price Targets & Ratings Chart

Analyst Chase Knickerbocker, currently employed at CRAIG HALLUM, has had 44.04% of price targets met with an average potential upside of 53.12%, reached in 185 days on average.

Chase Knickerbocker has documented 183 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MDXG, MiMedx Group at 27-Aug-2026.

Wall Street Analyst Chase Knickerbocker

Analyst best performing recommendations are on ETON (ETON PHARMACEUTICALS).
The best stock recommendation documented was for IRWD (IRONWOOD PHARMACEUTICALS) on 10/29/2025. The price target of $1.7 was fulfilled within 2 days with a profit of $0.19 (12.58%), with a performance score of 62.91.

Average potential price target upside

ACST Acasti Pharma AVDL Avadel Pharmaceuticals PLC BFLY Butterfly Network CVRX CVRx DCTH Delcath Systems DMAC DiaMedica Therapeutics ETON Eton Pharmaceuticals FENC Fennec Pharmaceuticals GH Guardant Health HROW Harrow Health INDV Indivior PLC IRWD Ironwood Pharmaceuticals KRMD Repro Med Systems MDWD Mediwound Ltd MDXG MiMedx Group PHAT Phathom Pharmaceuticals PYPD PolyPid SCPH Scpharmaceuticals CELC Celcuity LLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Dec-2022

$12

$12

2 years 1 months 26 days ago
(26-Sep-2024)

1/3 (33.33%)

$8.93 (290.88%)

3

Buy Since 26-Sep-2024

$8

2 years 1 months 26 days ago
(26-Sep-2024)

0/1 (0%)

$4.93 (160.59%)

Buy

$2.5

3 years 9 months 6 days ago
(15-Feb-2023)

1/1 (100%)

$1.86 (290.63%)

145

Buy Since 18-Jul-2019

$29.41

$30

4 years 4 months 30 days ago
(22-Jun-2022)

0/5 (0%)

$24 (443.62%)

Buy Since 09-Jul-2019

$12

$144

6 years 2 months 19 days ago
(02-Sep-2020)

1/2 (50%)

$1.58 (15.16%)

19

Show more analysts

Please expand the browser size to see the chart

Which stock is Chase Knickerbocker most bullish on?

Potential upside of $117.65 has been obtained for CELC (CELCUITY LLC)

Which stock is Chase Knickerbocker most reserved on?

Potential downside of $1.15 has been obtained for ETON (ETON PHARMACEUTICALS)

What Year was the first public recommendation made by Chase Knickerbocker?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?